Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Starmann, J; Fälth, M; Spindelböck, W; Lanz, KL; Lackner, C; Zatloukal, K; Trauner, M; Sültmann, H.
Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.
PLoS One. 2012; 7(10):e46584-e46584
Doi: 10.1371/journal.pone.0046584
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Lackner Karoline
- Spindelböck Walter Johann
- Trauner Michael
- Zatloukal Kurt
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Pathogenesis and factors for determining progression of alcoholic and non-alcoholic steatosis to steatohepatitis with risk of further progression to liver cirrhosis and cancer are poorly understood. In the present study, we aimed to identify potential molecular signatures for discrimination of steatohepatitis from steatosis. Global microarray gene expression analysis was applied to unravel differentially expressed genes between steatohepatitis compared to steatosis and control samples. For functional annotation as well as the identification of disease-relevant biological processes of the differentially expressed genes the gene ontology (GO) database was used. Selected candidate genes (n = 46) were validated in 87 human liver samples from two sample cohorts by quantitative real-time PCR (qRT-PCR). The GO analysis revealed that genes down-regulated in steatohepatitis were mainly involved in metabolic processes. Genes up-regulated in steatohepatitis samples were associated with cancer progression and proliferation. In surgical liver resection samples, 39 genes and in percutaneous liver biopsies, 30 genes were significantly up-regulated in steatohepatitis. Furthermore, immunohistochemical investigation of human liver tissue revealed a significant increase of AKR1B10 protein expression in steatohepatitis. The development of steatohepatitis is characterized by distinct molecular changes. The most striking examples in this respect were KRT23 and AKR1B10, which we found to be highly differentially expressed in steatohepatitis compared to steatosis and normal liver. We propose that KRT23 and AKR1B10 may serve as future potential biomarkers for steatohepatitis as well as markers for progression to HCC.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Aldehyde Reductase - genetics
- Aldehyde Reductase - metabolism
- Biomarkers, Tumor - genetics
- Biomarkers, Tumor - metabolism
- Case-Control Studies -
- Cluster Analysis -
- Fatty Liver - metabolism
- Female -
- Hepatitis C, Chronic - metabolism
- Humans -
- Keratins, Type I - genetics
- Keratins, Type I - metabolism
- Liver - metabolism
- Liver Neoplasms - metabolism
- Male -
- Middle Aged -
- Oligonucleotide Array Sequence Analysis -
- Principal Component Analysis -
- Transcriptome -
- Up-Regulation -
- Young Adult -